ThermoGenesis Corp. (KOOL) reported a fourth-quarter net loss of $0.7 million or $0.04 per share, narrower than the net loss of $1.2 million or $0.07 per share in the comparable quarter last year.
Net revenues for the latest quarter declined to $4.5 million from $5.4 million last year.
The company attributed the decline in revenues to decreased sales of BioArchive System devices, reflecting the continuing softness in worldwide capital equipment purchase activity.
ThermoGenesis is a supplier of enabling technologies for the processing, storage and administration of cell therapies.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.